ARTICLE | Company News
Stabilitech, U.S. Department of Defense infectious news
August 30, 2010 7:00 AM UTC
Stabilitech received a three-year contract from the DoD's Defense Threat Reduction Agency (DTRA) worth up to $4 million to use the biotech's vaccine stabilization technology to stabilize adenovirus-ve...